CBS and hepatocellular carcinoma: To further examine the underlying mechanisms causing an upregulation of BHMT and a downregulation of CBS, we explored whether PPARα-activation by the agonist WY14,643 in rat hepatoma cells (Fao) can cause similar changes in gene expression in vitro as observed in the livers of obese mice.